CannMed showcases the greatest minds in cannabis science, medicine, cultivation, and safety.CannMed was founded by Medicinal Genomics to promote understanding of cannabis' complex science and its medical benefits for patients in need. Since its founding in 2016, cannabis industry leaders have chosen CannMed to announce their latest findings and present breakthrough technologies to the world. Read more about CannMed 2020 Conference September 20-22
Avi Priel & Masha Niv - Towards novel migraine drugs: activation of the pain receptor TRPA1 by cannabinoids
Joseph Tam, Amiram Goldblum & Yuval Tabach - Discovery and Experimental Confirmation of Novel (Dual-Targeted) Peripherally Restricted CB1 Receptor Antagonists
The 2017 Israel Medical Convention will focus on medical cannabis. Prof. Raphael Mechoulam, Head of the MCCR Academic Committee, will give a lecture on the past and future of cannabis.
Dr. Ofra Benny - Studying the anti-angiogenic and anti-cancer activity of cannabinoid receptor 2 (CB2) agonists
Prof. Elyad Davidson - Effect of a cannabis extract on acute radicular pain and on analgesics. Requirement: a double-blinded, randomized, 24 hours follow-up study
Prof. Rami Yaka & Prof. Oren Ostresetzer - The Effects of CBD on Traumatic Brain Injury